DV
Dividend Vision

GYRE — Gyre Therapeutics Inc.

Gyre Therapeutics Inc. (GYRE)

Total return is -99.9% over the past 20.3 years, 873.7 points behind SPY at 773.8%. Its deepest 1-year drawdown was 37.3%.

This is a single-stock equity holding in Gyre Therapeutics Inc., a therapeutic company, rather than a diversified ETF. The fund provides direct exposure to the stock's price movements without a stated dividend distribution or expense ratio information available. This structure appeals primarily to investors seeking targeted exposure to the underlying company's performance rather than those prioritizing regular income distributions.

GYRE key facts

Asset type
Stock
Asset class
Equity
Inception date
04/12/2006
Last close
$6.68
Market cap
$674,507,520
Average volume
52700.0
Ex-dividend date
01/13/2023
Beta
4.775
Payout ratio
0.0
Forward P/E
78.125
EPS
$-0.08